Group D (dexmedetomidine group)Group L (Lidocaine group)
Group D (dexmedetomidine group): group D (Dexmedetomidine group) will recieve a dose of 1 mcg/kg
Group L (Lidocaine group): will recieve Lidocaine 2%, 1 mg/kg
Study summary
The aim of the study is to compare the effect of nebulized Dexmedetomidine compared to nebulized Lidocaine on postoperative sore throat in childern undergoing Tonsillectomy.
Eligibility
Sex
FEMALE
Min age
3 Years
Max age
15 Years
Healthy volunteers
No
Inclusion Criteria:
* Age: Childern between 3:15 years old
* American Society of Anesthesiologists(ASA) Physical Status I or II
* Elective Tonsillectomy
Exclusion Criteria:
* Parents refusal
* Presence of preoperative sore throat
* Known allergy to the study drug
* History of upper respiratory tract infection 2 weeks prior to surgery
* Mental retardation or inability to communicate
* Significant Cardiovascular disease as Heart Block
* Post Tonsillectomy bleeding
Primary outcome measure(s)
Incidence of Postoperative Sore Throat (POST) — immediately on PACU
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.